FDA Schedules Advisory Committee Meeting To Discuss BLA For VEGF Trap-Eye For The Treatment Of Wet Age-Related Macular Degeneration

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the U.S...

Full Story →